We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

138 hedge funds and large institutions have $334M invested in Rigel Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 50 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more capital invested

Capital invested by funds: $265M → $334M (+$68.7M)

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

2% more funds holding

Funds holding: 135 → 138 (+3)

0.32% less ownership

Funds ownership: 8.6% → 8.27% (-0.32%)

28% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 50

42% less call options, than puts

Call options by funds: $980K | Put options by funds: $1.69M

Holders
138
Holders Change
+3
Holders Change %
+2.22%
% of All Funds
2.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
36
Reduced
50
Closed
19
Calls
$980K
Puts
$1.69M
Net Calls
-$712K
Net Calls Change
-$707K

Top Buyers

1
State Street
State Street
Massachusetts
+$16.1M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.11M
3
Morgan Stanley
Morgan Stanley
New York
+$3.76M
4
SGA
Sector Gamma AS
Norway
+$3.35M
5
RG
Redmile Group
California
+$1.83M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$5.98M
2
NMC
NEA Management Company
Maryland
-$5.93M
3
PAI
Palo Alto Investors
California
-$5.79M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.67M
5
CS
Candriam SCA
Luxembourg
-$4.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$50.9M -$627K -25,530 -1%
BlackRock
2
BlackRock
New York
$41.3M -$60.5K -2,466 -0.1%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$32.9M -$4.67M -190,120 -12%
State Street
4
State Street
Massachusetts
$24.3M +$16.1M +654,265 +184%
Vanguard Group
5
Vanguard Group
Pennsylvania
$21.4M -$280K -11,418 -1%
TA
6
Tamarack Advisers
California
$18M +$1.6M +65,000 +9%
Citadel Advisors
7
Citadel Advisors
Florida
$15M +$4.11M +167,396 +36%
Invesco
8
Invesco
Georgia
$12M +$1.18K +48 +0%
RSCM
9
Rock Springs Capital Management
Maryland
$11.4M -$2.84M -115,475 -20%
Renaissance Technologies
10
Renaissance Technologies
New York
$8.11M -$5.98M -243,727 -42%
Hudson Bay Capital Management
11
Hudson Bay Capital Management
Connecticut
$7.64M -$329K -13,385 -4%
Morgan Stanley
12
Morgan Stanley
New York
$6.95M +$3.76M +153,318 +113%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$6.13M +$133K +5,424 +2%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$5.03M +$37.2K +1,517 +0.7%
Northern Trust
15
Northern Trust
Illinois
$4.78M -$298K -12,130 -6%
RPAM
16
Rhenman & Partners Asset Management
Sweden
$4.17M – – –
Arrowstreet Capital
17
Arrowstreet Capital
Massachusetts
$4.03M +$1.41M +57,557 +52%
Macquarie Group
18
Macquarie Group
Australia
$3.85M – – –
SGA
19
Sector Gamma AS
Norway
$3.28M +$3.35M +136,529 New
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
$2.9M -$503K -20,472 -15%
PAI
21
Palo Alto Investors
California
$2.84M -$5.79M -235,846 -67%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$2.48M +$440K +17,910 +21%
PAM
23
Panagora Asset Management
Massachusetts
$2.48M +$181K +7,378 +8%
Los Angeles Capital Management
24
Los Angeles Capital Management
California
$2.26M +$835 +34 +0%
Goldman Sachs
25
Goldman Sachs
New York
$2.24M +$1.49M +60,599 +185%
1
2 3 4 5

RIGL Hedge Fund Activity: Q3 2020 in Review

138 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q3 2020, worth a combined $334M — up 26% from $265M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new RIGL positions and 19 closed out — a net gain of 3 holders — while 36 added to existing stakes and 50 trimmed.

The largest buyer was State Street, adding an estimated $16.1M. The largest seller was Renaissance Technologies, cutting an estimated $5.98M.

  • 138 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q3 2020, up from 135 in Q2 2020.
  • Funds reported $334M of Rigel Pharmaceuticals stock for Q3 2020, up 26% quarter-over-quarter.
  • 22 funds opened new Rigel Pharmaceuticals positions in Q3 2020 and 19 closed out, a net change of +3 holders.
  • The largest Rigel Pharmaceuticals buyer in Q3 2020 was State Street, an estimated $16.1M added.
  • The largest Rigel Pharmaceuticals seller in Q3 2020 was Renaissance Technologies, an estimated $5.98M sold.

Based on aggregated 13F filings for Q3 2020.